Toronto Stocks Climb; SNC-Lavalin Higher on Quebec Bridge Project Contract Win
By Adriano Marchese
Toronto stocks were firmly in green territory Tuesday at midday, with all sectors pushing the indexes higher. At the top of the gainers list were Canadian tech stocks, followed by consumer durables and process industries.
Canada's S&P/TSX Composite Index rose by 0.6% to 21997.97 and the blue-chip S&P/TSX 60 rose by 0.5% to 1320.22.
Shares of SNC-Lavalin Group were 3.4% higher at 55.81 Canadian dollars ($40.74) after it said it was awarded a contract to support the development of the new Ile d'Orleans Bridge over the St. Lawrence River in Quebec.
Other market movers:
Silvercorp Metals shares were 3.7% higher at C$4.87 after it said it anticipates further production growth over the coming year, following a jump in gold and silver output in the last fiscal quarter.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
April 23, 2024 12:16 ET (16:16 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks